The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Hepatocellular carcinoma: State of the art diagnostic imaging
World J Radiol. 2023 Mar 28;15(3):56-68. doi: 10.4329/wjr.v15.i3.56.
1Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, United States.
2Department of Radiology, The Ohio State University Medical Center, Columbus, OH 43210, United States.
3Department of Radiology, The Ohio State University Medical Center, Columbus, OH 43210, United States. mina.makary@osumc.edu.
Abstract
Primary liver cancer is the fourth most common malignancy worldwide, with hepatocellular carcinoma (HCC) comprising up to 90% of cases. Imaging is a staple for surveillance and diagnostic criteria for HCC in current guidelines. Because early diagnosis can impact treatment approaches, utilizing new imaging methods and protocols to aid in differentiation and tumor grading provides a unique opportunity to drastically impact patient prognosis. Within this review manuscript, we provide an overview of imaging modalities used to screen and evaluate HCC. We also briefly discuss emerging uses of new imaging techniques that offer the potential for improving current paradigms for HCC characterization, management, and treatment monitoring.